| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | Director, Former 10% Owner
7 companies
Akkaraju Srinivas is a Director at ALMS, with reported holdings spanning 7 companies. Recent filings cover 44 purchases and 11 sales. Those positions are worth an estimated $64.8M at current prices.
Our model assigns Akkaraju Srinivas a strong insider score of 81/100, based on 23 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +59.9%.
Akkaraju Srinivas's largest disclosed position is in ALMS as Director, worth about $52.5M. Net of sales, the recent Form 4 record there shows accumulation of 3,064,368 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 159,327 | $13.10 | $2,086,395.68 | -11.1% | |
| Jul 1, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 4,627 | $11.01 | $50,965.94 | -0.3% | |
| Jun 25, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 154,700 | $11.11 | $1,718,567.77 | -9.7% | |
| Apr 9, 2019 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 533,332 | $7.50 | $3,999,990.00 | +50.3% | |
| Jan 31, 2018 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 209,424 | $9.55 | $1,999,999.20 | +24.6% | |
| Dec 14, 2017 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 109,774 | $9.03 | $991,557.60 | +15.2% | |
| May 12, 2015 | ATYR Atyr Pharma Inc | Director, Former 10% Owner | Buy | 320,000 | $14.00 | $4,480,000.00 | +20.7% |